Dynavax Technologies Corporation Company
Dynavax Technologies Corporation (Nasdaq: DVAX) is a fully-integrated biopharmaceutical company focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation. Dynavax develops, and commercializes novel vaccines.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership